topotecan has been researched along with glutamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Du, HZ; He, JY; Jiang, JW; Li, ZZ; Liu, Y; Sun, L; Wang, L; Yuan, ST; Zhang, BJ; Zhao, TL | 1 |
| Qin, M; Yang, J; Yu, H; Zhang, X; Zhou, G | 1 |
1 review(s) available for topotecan and glutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for topotecan and glutamine
| Article | Year |
|---|---|
Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutamine; Glutathione; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Minor Histocompatibility Antigens; Mitochondria; Molecular Targeted Therapy; Oxidative Stress; Stomach Neoplasms; Topotecan | 2019 |
Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress.
Topics: Amino Acid Transport System ASC; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemical and Drug Induced Liver Injury; Glutamine; Glutathione; Hep G2 Cells; Hepatocytes; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Reactive Oxygen Species; Topoisomerase I Inhibitors; Topotecan | 2021 |